| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Aquatic Bioscience (K.O., Y.Y., K.A.), Graduate School of Agricultural and Life Sciences, and Department of Integrated Biosciences (S.N., R.K., H.K.), Graduate School of Frontier Sciences, The University of Tokyo, Bunkyo, Tokyo 113-8657, Japan; and Department of Integrated Biosciences (H.M., M.K., A.S.), Graduate School of Frontier Sciences, The University of Tokyo, and Department of Biological Sciences (K.N.), Graduate School of Science, The University of Tokyo, Bunkyo, Tokyo 113-0033, Japan
Address all correspondence and requests for reprints to: Dr. K. Aida, Department of Aquatic Bioscience, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo, Tokyo 113-8657, Japan. E-mail: aida{at}uf.a.u-tokyo.ac.jp
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
GnRHs exert their actions through interactions with specific receptors that belong to the rhodopsin-like G protein-coupled receptor (GPCR) family (5, 6). GnRH receptors (GnRH-Rs) have been isolated from several mammalian and nonmammalian vertebrate species (6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16). Notably, the mammalian GnRH-R has a unique feature in that it is the only GPCR cloned to date that has a truncated cytoplasmic C-terminal tail. It is hypothesized that the cytoplasmic tail was lost on the evolutionary lineage between nonmammalian vertebrates and mammals (10, 12). It has also been suggested that multiple subtypes of GnRH-R are present in individual vertebrate species, based on increasing evidence showing the occurrence of varied GnRH ligand forms in one organism and the distribution of GnRH-binding sites (17). Nevertheless, until quite recently, only a single subtype of GnRH-R had been isolated from each species. Troskie et al. (18), however, have obtained the partial sequences for two candidate GnRH-R genes in the goldfish Carassius auratus, zebrafish Danio rerio, Xenopus laevis, and lizard Agama atra. Subsequently, three full-length GnRH-Rs have been isolated in the bullfrog Rana catesbeiana (19). Neill et al. (20) have cloned second primate GnRH-Rs, which have a cytoplasmic C-terminal tail, unlike other mammalian GnRH-Rs isolated so far. The multiplicity of GnRH-Rs in one organism then raised the following questions: (a) Do other vertebrates besides the bullfrog and primates also have multiple GnRH-Rs; (b) do they have different structural, pharmacological, and/or physiological characteristics; and (c) what are the phylogenetic relationships among multiple GnRH-Rs?
To answer these questions, we have taken one freshwater teleost fish, the medaka Oryzias latipes, as an experimental model system. This fish is a promising model organism for reproductive, developmental, phylogenetic, and genetic studies because of its many useful characteristics such as its well-established reproductive biology and genetics, short generation time, and availability of a large number of inbred strains and mutants (21, 22, 23). Our previous study demonstrated that the medaka possesses three molecular forms of GnRH in its central nervous system; medaka-type GnRH (mdGnRH) expressed in the preoptic area probably as the stimulator of gonadotropin secretion, cGnRH-II in the midbrain tegmentum, and salmon-type GnRH (sGnRH) in the terminal nerve ganglia (24).
In the present study, we report the presence of two distinct GnRH-R subtypes, termed GnRH-R1 and GnRH-R2, in the medaka. We have isolated the cDNAs encoding these two GnRH-Rs and determined the nucleotide sequence, structural organization, copy number, and chromosomal assignment of their genes. The ability of the cloned receptors to couple to the inositol phosphate (IP) second-messenger pathway was investigated using COS-7 cells transiently expressing the GnRH-Rs. In addition, we propose a novel classification of vertebrate GnRH-R subtypes based on phylogenetic analysis in combination with the differences in their protein and gene structures and pharmacological characteristics.
| Materials and Methods |
|---|
|
|
|---|
After determination of the partial cDNA sequences, rapid amplification of cDNA ends (RACE) was carried out to isolate the full-length cDNAs as described before (13). Gene-specific primers, R1-F1 (5'-AAAACGTTTCCTCCGACGAGCCG-3'; nt 11781200)/R1-F2 (5'-GCCGCATCTGCGCTGCTCAAAG-3'; nt 11971218) and R2-F1 (5'-CAGGTGAATCACATCTTCGTCGCAGC-3'; nt 962987)/R2-F2 (5'-GTGCTGGACGCCATACTACCTGCTG-3'; nt 10621086) were designed to use as primary/nested primers for 3'-RACE of the GnRH-R1 and GnRH-R2, respectively. Primers, R1-R1 (5'-TTTTTTGGTCATCTGCTTGGAGATCTG-3'; nt 11791153)/R1-R2 (5'-GTAGCAGATGATCATGATGATGAGC-3'; nt 11131137) and R2-R1 (5'-GGCGTGCATGGCAAACAGCTTCAGG-3'; nt 594618)/R2-R2 (5'-GCAGAGCA-GCTTGCACAGAGCGTC-3'; nt 568591) were also designed as primary/nested primers for 5'-RACE of the GnRH-R1 and GnRH-R2, respectively. Electrophoresis, subcloning, and sequencing were performed as described above.
Sequence analysis was performed using Sequencher software version 3.1.1 (Hitachi) and SeqEd software version 1.0.3 (Perkin-Elmer Corp., Branchburg, NJ). The nucleotide sequence was determined by analyzing more than four clones from distinct amplifications to avoid PCR errors.
Comparison of the GnRH-Rs of the medaka and other
vertebrates
The deduced amino acid sequences of the GnRH-Rs in the medaka
and other vertebrates were aligned using CLUSTAL W (25)
with default setting. Sequence identity among TM domains I-VII in the
GnRH-Rs of the medaka and other vertebrates was calculated using Mac
Vector version 6.0 (Oxford Molecular, Beaverton,
OR).
Isolation of the medaka GnRH-R genes
Genomic DNA was extracted from the muscle of a medaka strain,
himedaka, as described elsewhere (26). The two GnRH-R
genes were isolated by means of PCR amplifications of partial sequences
and alignment of the contigs by sequence analysis. The following primer
pairs were used to amplify GnRH-R1 and GnRH-R2 genes: for the GnRH-R1
gene, R1-F3 (5'-CACAGACCAATCATCTGCACGCGG-3'; nt 124)/R1-R3
(5'-CACCGGCATCACGATGAAGGTGAC-3'; nt 724748), R1-F4
(5'-CCACAAGCGCAAGTCTCACGTCCG-3'; nt 663686)/R1-R4
(5'-TCCTGCCAGTGGGTCACGAAGCTC-3'; nt 10441067), R1-F5
(5'-CAAACTTCACCCAGTGCACCACTAGAG-3'; nt 10161042)/R1-R5
(5'-ACGCTCATCTTCAGAGTTCTCATCCG-3'; nt 12371262), R1-F6
(5'-GCCGCATCTGCGCTGCTCAAAG-3'; nt 11971218)/R1-R6
(5'-CCCGGTGTGAACATAGCATCAGACG-3'; nt 17031727), R1-F7
(5'-TCATCTTCGGGCTTTTCAACACCTGC-3'; nt 13821407)/R1-R7
(5'-ATTGCAGGAATTGTACGACACCAAGTC-3'; nt 20532079), and R1-F8
(5'-TCAGCGGGTTCAAGTCTTGCGAAAC-3'; nt 19842008)/R1-R8
(5'-GGCTGGTTCATCTGCAGACACCACT-3'; nt 27122736); for the GnRH-R2 gene,
R2-F3 (5'-CTACTGGACCGACATGGAGCCGAG-3'; nt 175198)/R2-R3
(5'-GGCGTGCATGGCAAACAGCTTCAGG-3'; nt 594618), R2-F4
(5'-GGTGACGCTCTGTGCAAGCTGCTC-3'; nt 565588)/R2-R4
(5'-CCAGCGATGACTAAAGCTGCCATGAG-3'; nt 815840), R2-F5
(5'-CTCTTCAGGACCATCAAAGTCGACCG-3'; nt 766791)/R2-R5
(5'-CGAGCCTTTGGGATGATGTCTGTGC-3'; nt 989-1013), R2-F6
(5'-CAGGTGAATCACATCTTCGTCGCAGC-3'; nt 962987)/R2-R6
(5'-TAATCCATGGACACCAGTGAAGATCAC-3'; nt 14901516), and R2-F7
(5'-CCTTGTTCTATCCTAGGCACTTTAACG-3'; nt 14011427)/R2-R7
(5'-AGTGTGTCAGAATAAAAGCTTTAAGCGTC-3'; nt 18631891). The PCR products
were electrophoresed on 2.0% agarose gels and ligated into pCR-TOPO
vector (Invitrogen, Groningen, The Netherlands). The
plasmid DNA was purified, and both directions of the DNA were sequenced
using two DNA sequencers, Long-Read Tower (Amersham Pharmacia Biotech, Buckinghamshire, Little Chalfont, UK) and SQ-5500
(Hitachi). Sequence analysis was performed as described
above. Within introns, several nucleotide sequence differences, which
could be owing to interspecific polymorphisms, occurred. Thus, only the
consensus sequences were deposited into the database.
Genomic Southern blot analysis
Genomic DNA of the himedaka was digested with
DraI, Eco T14, HindIII, or
PstI. Ten micrograms of DNA were electrophoresed on 0.8%
agarose gels and transferred to nylon membranes
(Hybond-N+; Amersham Pharmacia Biotech). Digoxigenin-labeled cDNA probes for GnRH-R1 (323 bp)
and GnRH-R2 (270 bp) were generated by PCR amplification with DIG DNA
labeling mix (Roche, Grenzach-Wyhlen, Germany)
and primer pairs, R1-F9 (5'-TGCCTGGACCCCATCATCTACG-3'; nt
14051426)/R1-R9 (5'-CCCGGTGTGAACATAGCATCAGACG-3'; nt 17031727)
and R2-F8 (5'-CCAGCCTGACATGCTACGTGTC-3'; nt 11041125)/R2-R8
(5'-AATGCGAACGAGCGGTCCAGTG-3'; nt 13521373),
respectively. The membranes were prehybridized at 68 C for 2 h
with hybridization buffer containing 5x SSC, 1% blocking reagent
(Roche), 0.1% N-lauroyl-sarcosine, and 0.02%
SDS. Hybridization was carried out overnight at 68 C with the
hybridization buffer containing the labeled probes. The membranes were
subsequently washed with 2x SSC containing 0.1% SDS and with 0.1x
SSC containing 0.1% SDS. Signals were visualized with antidigoxigenin
antibodies conjugated to alkaline phosphatase and CDP-Star as a
substrate (Roche).
Interspecific backcross mapping
Several parts of the GnRH-R genes of two inbred strains of the
medaka, HNI and AA2, were sequenced. Insertion/deletion polymorphisms
between the two strains were found within intron B of the GnRH-R1 gene
and intron A of the GnRH-R2 gene. The following primer pairs were
designed to amplify the polymorphism-containing sequences: R1-F10
(5'-AGGACAGTCAAATCTGACCT-3')/R1-R10
(5'-TATGAGAAAT(C/T)ACTCATCCTTACT-3') and R2-F9
(5'-CCCACTGAAAGTTCTGCATG-3')/R2-R9 (5'-ATCAGTCAGGAGATTCTGCT-3') for the
GnRH-R1 and GnRH-R2 genes, respectively. PCR amplification of the HNI
and AA2 genomic DNAs with R1-F10/R1-R10 yielded DNA fragments of 110
and 122 bp, respectively. Amplification of the HNI and AA2 genomic DNAs
with R2-F9/R2-R9 produced fragments of 103 and 81 bp, respectively.
Chromosomal assignments of these two genes were determined using
reference-typing DNA panels derived from 39 offspring of a backcross
between an HNI/AA2 male F1 and an AA2 female parental line
(27). Genotypes were analyzed by amplification of the
polymorphic DNA regions followed by 10% PAGE. PCR was carried out
under a cycle protocol of 94 C for 1 min, 40 cycles of 94 C for 30 sec,
50 (GnRH-R1) or 58 C (GnRH-R2) for 30 sec, and 72 C for 30
sec.
IP assay
The cDNAs containing full-length open reading frames for GnRH-R1
and GnRH-R2 were subcloned into the expression vector pcDNA3
(Invitrogen). The plasmid DNA was transfected into
monolayer cultures of COS-7 cells in 100-mm dishes using TransFast
transfection reagent (Promega Corp., Madison, WI). After
24 h, cells were trypsinized, transferred to 12-well plates
(Corning, Inc., Corning, NY), and grown overnight. Cells
were subsequently labeled with 2 µCi/ml
myo[2-3H]inositol (Amersham Pharmacia Biotech) in inositol-free medium (Life Technologies, Inc., Rockville, MD) containing 2% heat-inactivated FCS and 50
µg/ml gentamicin. Cells were incubated for 24 h and then washed
and preincubated for 15 min at 37 C in IP buffer (1x HBSS, 20
mM HEPES, 20 mM LiCl, and 50 µg/ml
gentamicin, pH 7.55), followed by stimulation with various
concentrations of GnRH ligands in IP buffer for 1 h at 37 C, with
gentle agitation. The GnRH ligands used in the assay were mdGnRH
(synthesized by Sawady Technology, Tokyo, Japan), cGnRH-II
(Phoenix Pharmaceuticals, Inc., Belmont, CA), sGnRH
(Sigma, St. Louis, MO), and mammalian-type GnRH (mGnRH)
(Sigma). The production of total IP including IP,
IP2, and IP3 was assessed
as described by Berg et al. (28). Experiments
were performed in triplicate and repeated at least twice. Data obtained
were analyzed using PRISM software(GraphPad Software, Inc., San Diego, CA).
Phylogenetic analysis of vertebrate GnRH-Rs
A phylogenetic tree was generated by PHYLIP software
(29) using the neighbor-joining method (30).
The full-length GnRH-R polypeptide was used to generate the tree.
Bootstrap values were calculated by PHYLIP. The Drosophila
GnRH-R homolog was used as an outroot (31). Full species
names and GenBank accession numbers of the species used to generate the
tree are as follows: eel Anguilla japonica, AB041327; trout
Oncorhynchus mykiss, OMY272116; goldfish Carassius
auratus GfA, AF121845; GfB, AF121846; catfish Clarias
gariepinus, CHFNRHR; Xenopus laevis, AF172330; bullfrog
Rana catesbeiana GnRH-R1, AF144063; GnRH-R2, AF153913;
GnRH-R3, AF144062; chicken Gallus gallus, AJ304414; striped
bass Morone saxatilis, AF218841; sheep Ovis
aries, SHPGRHR; cow Bos taurus, BTU00934; human
Homo sapiens, S60587; dog Canis familiaris,
AF206513; mouse Mus musculus, MUSGRHR; rat Rattus
norvegicus, S59525; possum Trichosurus vulpecula,
AF032379; rhesus monkey Macaca mulatta, AF353987; African
green monkey Cercopithecus aethiops, AF353988; and
Drosophila melanogaster, AF077299.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Both GnRH-R1 and GnRH-R2 contain seven TM domains and an extracellular N terminus. Each of them also has a cytoplasmic C-terminal tail, which is a common characteristic to nonmammalian GnRH-Rs identified so far. The cytoplasmic tails of the two GnRH-Rs in the medaka, however, share no significant homology. In GPCRs, the cytoplasmic tail has been demonstrated to be associated with receptor desensitization and internalization (32, 33, 34). Therefore, it is possible that GnRH-R1 and GnRH-R2 exhibit distinct patterns of desensitization and internalization.
Southern blot analysis revealed that both GnRH-R1 and GnRH-R2 are encoded by single copy genes. These receptors, however, show remarkable differences in gene organization. The GnRH-R1 and GnRH-R2 genes have two introns, termed introns B and C, at identical positions in the genes (TM IV and third cytoplasmic loop, respectively), but there is another intron, denoted intron A, in the extracellular domain of GnRH-R2. All mammalian GnRH-R genes have two introns corresponding to introns B and C in TM IV and the third cytoplasmic loop but lack intron A (6, 20). On the other hand, the Xenopus GnRH-R contains three introns at the same location as the medaka GnRH-R2 (12). The conservation of the location of introns B and C supports the idea that multiple GnRH-Rs arose from a duplication event sometime in the past (5, 18). Although it is unknown whether the ancestral GnRH-R gene was composed of four exons/three introns or three exons/two introns, intron A should be lost or appended in some GnRH-R genes during evolution. In terms of the evolution of the GnRH-R gene, the assignment of the two GnRH-R genes in the medaka to distinct chromosomes eliminates the possibility that these receptor genes have arisen by tandem duplication of their progenitor gene.
When expressed in COS-7 cells, the medaka GnRH-R1 and GnRH-R2 stimulated IP formation in response to GnRH ligands. We used three native GnRH forms in the medaka (mdGnRH, cGnRH-II, and sGnRH) and a mammalian ortholog to the mGnRH as experimental ligands. GnRH-R1 and GnRH-R2 showed the same preference of potencies for GnRH ligands with cGnRH-II > sGnRH > mGnRH > mdGnRH and exhibited the almost same EC50 value for cGnRH-II (0.52 and 1.0 nM, respectively). However, there was a significant difference in the ligand selectivity between GnRH-R1 and GnRH-R2: The sensitivities of GnRH-R1 for sGnRH, mGnRH, and mdGnRH were approximately 100 times greater than those of GnRH-R2.
It is noteworthy that GnRH-R2 exhibited less sensitivity for mGnRH than did GnRH-R1. An acidic residue in the third extracellular loop of mammalian GnRH-Rs (i.e., Glu301 in the mouse and Asp302 in the human GnRH-Rs) is thought to be responsible for high selectivity for mGnRH ligand form, which possesses Arg in position 8 (35). The acidic residue in the third extracellular loop is also conserved as Glu308 in the medaka GnRH-R2 but is replaced by His311 in the medaka GnRH-R1. Therefore, the lower sensitivity of GnRH-R2 for mGnRH was an unexpected observation. It could be that the GnRH-Rs in the medaka have different ligand-binding sites from mammalian GnRH-Rs.
Another intriguing aspect of the pharmacology of the medaka GnRH-Rs is the finding that both receptors exhibited highest selectivities for cGnRH-II, physiological function of which is still unknown. This GnRH form occurs along with one or two other forms in all vertebrates examined so far including humans (36) and the medaka (24). The cGnRH-II-producing neurons are distributed in the midbrain tegmentum and project their axons throughout the brain (3, 4, 5). These lines of evidence suggest the importance of cGnRH-II in the central nervous system. Additional characterization of cGnRH-II and its possible receptor(s) will facilitate the understanding of physiological roles of this GnRH form.
We also examined the expression of the two GnRH-Rs in the brain and pituitary of the medaka. RT-PCR analysis demonstrated the presence of mRNAs for both GnRH-R1 and GnRH-R2 in the pituitary glands of adult medakas, suggesting that both receptors are implicated in the stimulation of gonadotropin secretion from this tissue (data not shown). In the medaka, mdGnRH is considered to be the hormone that stimulates gonadotropin secretion (23). Thus it is surprising that both of the GnRH-Rs expressed in the pituitary exhibited less sensitivity to mdGnRH than the other two native ligand forms in the medaka. One possible explanation for this phenomenon is that an additional GnRH-R that prefers mdGnRH exists in the pituitary besides the GnRH-R1 and GnRH-R2. The possibility of the occurrence of a third GnRH-R will be discussed below.
In addition to expression in the pituitary, GnRH-R1 and GnRH-R2 were found to be expressed throughout the brain (data not shown). This observation predicts physiological roles for these two receptors in the brain, although the precise functions of GnRHs in this organ remain to be elucidated. Several lines of evidence have demonstrated that GnRH, when administered in the brain, promotes the lordosis reflex, a sexual receptive behavior of the female rat (37, 38). GnRH was also shown to modulate reproductive behavior in teleosts including the dwarf gourami Colisa lalia and goldfish (39, 40). One or both of the two GnRH-Rs, therefore, may mediate GnRH function as a neurotransmitter and neuromodulator to regulate reproductive behaviors. We did not observe any difference between the expression patterns of GnRH-R1 and GnRH-R2 in the central nervous system of the adult medaka. Thus, the natures of their physiological roles are still obscure. It is necessary to conduct further studies to determine their spatiotemporal expression and distribution patterns in detail.
A single vertebrate species has at least two distinct GnRH-R
subtypes
Within the teleost lineage, the occurrence of two separate genes
has been reported for several substances including a homeobox gene
(41), cytochrome P450 aromatase (42, 43),
rhodopsin (44), and synaptosome-associated protein
(45). The duplicity of these genes is thought to result
from a genome duplication early in teleost evolution after the
divergence of teleosts and tetrapods (46, 47, 48). Thus, one
may suspect that the presence of the two GnRH-Rs in the medaka reported
in the present study was likewise caused by a duplicative event within
the teleost lineage and is therefore a restricted characteristic of
this lineage. GnRH-R1 and GnRH-R2 are, however, highly divergent,
sharing only 43% overall amino acid identity and 53% identity even in
the relatively highly conserved TM domains. Furthermore, phylogenetic
analysis revealed that the two GnRH-Rs in the medaka fell into distinct
lineages, each of which contains the bullfrog GnRH-R(s). These data
indicate that the medaka GnRH-R genes cloned here arose from a gene
duplication predating the divergence of teleosts and tetrapods. Hence,
the GnRH-R1 and GnRH-R2 should be representatives for different GnRH-R
subtypes, and the occurrence of these two GnRH-R subtypes would be a
common characteristic in teleosts and tetrapods. In support of
this notion, we have also identified a GnRH-R1-like gene, in addition
to a previously reported counterpart of the medaka GnRH-R2
(16), in one of the most primitive teleost species, the
eel Anguilla japonica (unpublished data).
In contrast, phylogenetic analysis demonstrated that two GnRH-Rs isolated from another teleost species, the goldfish (8), are variant forms within the same subtype. This might result from the genome duplication early in the evolution of teleosts. The bullfrog has been shown to possess three GnRH-Rs in its central nervous system, designated GnRH-Rs 1, 2, and 3 (19). However, the present phylogenetic analysis also placed the bullfrog GnRH-Rs 1 and 3 in the same lineage, suggesting that these two receptors in the bullfrog are also duplicated variant forms within a single subtype. In this amphibian species, several or all genes, probably including GnRH-R genes, may be duplicated, similar to the Xenopus. This idea is consistent with the result of genomic Southern blot analysis performed by Wang et al. (19), which showed two bands for the other GnRH-R in the bullfrog, the GnRH-R2. Therefore the present paper, in combination with the recent studies of the bullfrog and primates, provides evidence that a single vertebrate species has at least two distinct GnRH-R subtypes.
Evolution of vertebrate GnRH-R subtypes: the possible occurrence of
three GnRH-R subtypes in one organism
The medaka GnRH-R1 shares relatively high identity with the
striped bass GnRH-R, and bullfrog GnRH-Rs 1 and 3. In addition,
phylogenetic analysis clustered these genes into one lineage. Thus, it
is certain that they form one subtype lineage of vertebrate GnRH-Rs.
Phylogenetic analysis also showed that the recently reported second
primate GnRH-Rs belong to this subtype group.
According to a widely accepted classification (18), it is believed that the GnRH-Rs of teleosts including the catfish, goldfish, eel, and trout are orthologs to mammalian GnRH-Rs that lack a cytoplasmic tail. In this case, the medaka GnRH-R2 also should be classified into this subtype. However, this does not seem to be a true case because there are several crucial differences on the structural and pharmacological characteristics between the medaka GnRH-R2 and the mammalian GnRH-Rs. First, the medaka GnRH-R2 has a cytoplasmic C-terminal tail, which is absent in these mammalian GnRH-Rs. Second, the medaka GnRH-R2 gene consists of four exons separated by three introns, whereas the mammalian GnRH-R genes have three exons and two introns, resulting from the absence of intron A. Third, although relatively conserved TM domains were used for sequence alignments, the amino acid identities between the medaka GnRH-R2 and the mammalian GnRH-Rs were substantially low. Finally, the pharmacological studies have demonstrated that the medaka GnRH-R2 has over 100 times higher selectivity for cGnRH-II than the other GnRH ligands tested, but the cytoplasmic tail-lacking mammalian GnRH-Rs prefer mGnRH over other forms, including cGnRH-II. Therefore, similar to GnRH-R1, GnRH-R2 is not likely to be the medaka ortholog to the mammalian GnRH-Rs that lack a cytoplasmic tail. The phylogenetic tree constructed using the Drosophila GnRH-R homologue as an outroot indeed assigned the medaka GnRH-R1 and GnRH-R2 and the cytoplasmic tail-lacking mammalian GnRH-Rs to three separate lineages with high bootstrap values for principal nodes. These data led us to the idea that there may be three paralogous lineages in the evolution of vertebrate GnRH-Rs. Accordingly, it is logically possible that one vertebrate species has three distinct GnRH-R subtypes.
Based on the logic mentioned above, we propose a possible classification of vertebrate GnRH-R subtypes. The first subtype contains the medaka GnRH-R1, striped bass GnRH-R, bullfrog GnRH-Rs 1 and 3, and second primate GnRH-Rs. The upper lineage in the phylogenetic tree represents this subtype, possessing a cytoplasmic C-terminal tail but lacking intron A. The second subtype represented by the middle lineage in the tree includes the medaka GnRH-R2 and other GnRH-Rs found in several teleosts, amphibia, and chickens. This subtype also has a cytoplasmic tail, and its gene contains intron A. The third subtype represented by the lower lineage in the tree contains only the GnRH-Rs that have been found in mammals. Unlike the first and second subtypes, the third subtype lacks a cytoplasmic tail and also lacks intron A.
In humans, only one functional GnRH-R has been identified to date. It is uncertain whether other functional GnRH-Rs occur in humans. Recently, Millar et al. (49) have found the human genomic DNA sequence showing high homology of over 40% with the functional human GnRH-R and referred to it as a putative second GnRH-R, but its transcript could not be detected. Instead of the putative second GnRH-R-encoding sense DNA, its antisense DNA is shown to be highly transcribed in various tissues and encodes a ribonucleoprotein (50). This putative second GnRH-R gene contains only two intronic sequences, the locations of which are the same as introns B and C in the medaka GnRH-R genes. Also, this human gene sequence resembles the second GnRH-Rs in primates (20), which belong to the same subtype group as the medaka GnRH-R1 as described above. Therefore, humans would have the second GnRH-R subtype that is orthologous to the medaka GnRH-R1, although it could have become a pseudogene during evolution. It is of interest to note that a GnRH-R gene that has intron A, which the medaka GnRH-R2 possesses, has not been identified in humans. However, the present phylogenetic analysis logically suggests the existence of a human ortholog of the medaka GnRH-R2. Further studies are required to determine whether humans possess another GnRH-R gene that contains intron A.
Conservation of synteny is often seen between the genomes of humans and teleosts including the medaka and zebrafish (27, 46, 47, 48, 51, 52). This phenomenon allows the definition of the relationship between genes of humans and these teleosts. The human GnRH-R gene was mapped to 4q1321 (53), and the putative second GnRH-R sequences in the human genome were to 1q21.1 (49) and 14q21-q23 (50). In spite of our expectations, the present mapping of the medaka GnRH-R genes failed to find syntenies of these genes owing to the lack of appropriate genetic markers located near the GnRH-R genes. However, when the markers in the medaka linkage map grow denser in the near future, the present mapping would illuminate the evolutionary relationships among the diversified GnRH-R subtypes. Then it also could be determined whether the medaka has the orthologous gene to mammalian GnRH-Rs that probably consists of three exons/two introns and encodes a cytoplasmic tail-lacking receptor.
In conclusion, the present study has identified two distinct GnRH-R subtypes in a model teleost species, the medaka. Their genes have different structures and distinct chromosomal locations. The two receptor subtypes also showed distinct ligand preferences, with each receptor exhibiting particularly high sensitivity for cGnRH-II. Phylogenetic analysis proposed that a third GnRH-R subtype may remain to be found in the medaka.
| Acknowledgments |
|---|
| Footnotes |
|---|
1 Present address: National Research Institute of Aquaculture, Inland
Station, Hiruta, Tamaki, Mie 519-0423, Japan. ![]()
Abbreviations: cGnRH-II, Chicken-II-type GnRH; GnRH-R, GnRH receptor; GPCR, G protein-coupled receptor; IP, inositol phosphate; LG, linkage group; mdGnRH, medaka-type GnRH; mGnRH, mammalian-type GnRH; RACE, rapid amplification of cDNA ends; sGnRH, salmon-type GnRH; TM, transmembrane.
Received April 23, 2001.
Accepted for publication July 16, 2001.
| References |
|---|
|
|
|---|
-globin gene into rainbow trout. Nippon Suisan
Gakkaishi 57:819824
This article has been cited by other articles:
![]() |
C. A. Flanagan, C.-C. Chen, M. Coetsee, S. Mamputha, K. E. Whitlock, N. Bredenkamp, L. Grosenick, R. D. Fernald, and N. Illing Expression, Structure, Function, and Evolution of Gonadotropin-Releasing Hormone (GnRH) Receptors GnRH-R1SHS and GnRH-R2PEY in the Teleost, Astatotilapia burtoni Endocrinology, October 1, 2007; 148(10): 5060 - 5071. [Abstract] [Full Text] [PDF] |
||||
![]() |
M R Silver and S A Sower Functional characterization and kinetic studies of an ancestral lamprey GnRH-III selective type II GnRH receptor from the sea lamprey, Petromyzon marinus. J. Mol. Endocrinol., June 1, 2006; 36(3): 601 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okubo, F. Sakai, E. L. Lau, G. Yoshizaki, Y. Takeuchi, K. Naruse, K. Aida, and Y. Nagahama Forebrain Gonadotropin-Releasing Hormone Neuronal Development: Insights from Transgenic Medaka and the Relevance to X-Linked Kallmann Syndrome Endocrinology, March 1, 2006; 147(3): 1076 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Tello, J. E. Rivier, and N. M. Sherwood Tunicate Gonadotropin-Releasing Hormone (GnRH) Peptides Selectively Activate Ciona intestinalis GnRH Receptors and the Green Monkey Type II GnRH Receptor Endocrinology, September 1, 2005; 146(9): 4061 - 4073. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Silver, N. V. Nucci, A. R. Root, K. L. Reed, and S. A. Sower Cloning and Characterization of a Functional Type II Gonadotropin-Releasing Hormone Receptor with a Lengthy Carboxy-Terminal Tail from an Ancestral Vertebrate, the Sea Lamprey Endocrinology, August 1, 2005; 146(8): 3351 - 3361. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Moncaut, G. Somoza, D. M Power, and A. V M Canario Five gonadotrophin-releasing hormone receptors in a teleost fish: isolation, tissue distribution and phylogenetic relationships J. Mol. Endocrinol., June 1, 2005; 34(3): 767 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Cheng and P. C. K. Leung Molecular Biology of Gonadotropin-Releasing Hormone (GnRH)-I, GnRH-II, and Their Receptors in Humans Endocr. Rev., April 1, 2005; 26(2): 283 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gonzalez-Martinez, T. Madigou, E. Mananos, J. M. Cerda-Reverter, S. Zanuy, O. Kah, and J. A. Munoz-Cueto Cloning and Expression of Gonadotropin-Releasing Hormone Receptor in the Brain and Pituitary of the European Sea Bass: An In Situ Hybridization Study Biol Reprod, May 1, 2004; 70(5): 1380 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Millar, Z.-L. Lu, A. J. Pawson, C. A. Flanagan, K. Morgan, and S. R. Maudsley Gonadotropin-Releasing Hormone Receptors Endocr. Rev., April 1, 2004; 25(2): 235 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang, O. Yun, K. Maiti, D. Y. Oh, K. K. Kim, C. H. Chae, C. J. Lee, J. Y. Seong, and H. B. Kwon Position of Pro and Ser near Glu7.32 in the Extracellular Loop 3 of Mammalian and Nonmammalian Gonadotropin-Releasing Hormone (GnRH) Receptors Is a Critical Determinant for Differential Ligand Selectivity for Mammalian GnRH and Chicken GnRH-II Mol. Endocrinol., January 1, 2004; 18(1): 105 - 116. [Abstract] |